US Broker Ratings

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: A Biotech Player with 59.70% Upside Potential

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is making waves in the biotechnology sector with its innovative therapies aimed at enhancing the lives of patients with hematologic disorders and cancer. As a..

Absci Corporation (ABSI) Stock Analysis: Exploring a 153% Potential Upside in Biotechnology

Absci Corporation (NASDAQ: ABSI) is attracting considerable attention from the investment community, thanks to its significant potential upside of 153.27% based on current analyst ratings. As a clinical-stage biopharmaceutical company..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Unveiling a 139% Upside Potential in the Medical Device Sector

Investors looking for opportunities in the healthcare sector might find ClearPoint Neuro Inc. (NASDAQ: CLPT) an intriguing prospect. With a focus on minimally invasive surgical procedures in the brain, this..

Bausch + Lomb Corporation (BLCO)

⚠️ No article content returned.

..

Integer Holdings Corporation (ITGR) Stock Analysis: Insights into Its 9.56% Potential Upside and Market Position

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors seeking exposure to a company with robust growth..

Legend Biotech Corporation (LEGN) Stock Analysis: A Biotech Gem with 215% Upside Potential

Investors looking for promising opportunities in the biotech sector should consider Legend Biotech Corporation (NASDAQ: LEGN), a dynamic player in the field of cell therapies. With a market capitalization of..

Alkermes plc (ALKS) Stock Analysis: Key Insights on Its 32.60% Potential Upside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, primarily focuses on drug manufacturing in the specialty and generic segments. Headquartered in Dublin, Ireland, this biopharmaceutical company has..

Nuvalent, Inc. (NUVL): Investor Outlook with a 38.59% Upside Potential

Nuvalent, Inc. (NASDAQ: NUVL) is making waves in the biotechnology sector with its innovative approach to cancer treatment, particularly in addressing treatment resistance and CNS-related challenges. As a clinical-stage biopharmaceutical..

Cytokinetics, Incorporated (CYTK)

⚠️ No article content returned.

..

Guardant Health, Inc. (GH) Stock Report: Exploring a Potential 65% Upside

Investors keeping a watchful eye on the healthcare sector might find Guardant Health, Inc. (NASDAQ: GH) an intriguing prospect, with a potential upside of 65.05% according to analyst ratings. As..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unraveling the 79% Potential Upside in the Biotech Innovator

Vaxcyte, Inc. (NASDAQ: PCVX), a trailblazer in the biotechnology space, has been capturing the attention of investors with its innovative approach to vaccine development. As a clinical-stage company focused on..

Merit Medical Systems, Inc. (MMSI) Investor Outlook: Strong Buy Ratings and 48% Potential Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a distinguished name in the healthcare sector specializing in medical instruments and supplies, presents an intriguing opportunity for investors. The company’s robust market presence,..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Navigating a 63.13% Potential Upside in Biotechnology

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing the attention of investors with its promising pipeline in the biotechnology sector. This Boston-based company, with a market capitalization of $5.76 billion, is..

Hologic, Inc. (HOLX) Stock Analysis: Navigating a Stable Path in the Healthcare Market

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, has carved out a niche in the medical instruments and supplies industry. With a market cap of $16.97 billion,..

Regencell Bioscience Holdings (RGC) Stock Analysis: Insights Into Its Recent Surge and Market Position

Regencell Bioscience Holdings Limited (NASDAQ: RGC) has been capturing attention on the investment landscape, thanks to its remarkable journey in the healthcare sector. As a Hong Kong-based company specializing in..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Growth Potential Amidst Market Dynamics

Teleflex Incorporated (NYSE: TFX), a significant player in the healthcare sector, stands out in the medical instruments and supplies industry. With a market capitalization of $5.23 billion, Teleflex is known..

RadNet, Inc. (RDNT) Stock Analysis: Exploring a 66.65% Potential Upside in Healthcare Diagnostics

RadNet, Inc. (NASDAQ: RDNT) is drawing significant attention from investors due to its robust position in the healthcare sector and diagnostic imaging industry, combined with a promising potential upside of..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: What Investors Should Know About Its 14.24% Potential Upside

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is gaining attention from investors in the biotechnology sector, primarily due to its ambitious focus on developing treatments for rare diseases. With a market capitalization..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating the Potential Upside in Managed Care

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, is making waves with its strategic focus on providing managed healthcare services to low-income families under Medicaid..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring the 96.7% Potential Upside for Investors

Atrium Therapeutics, Inc. (NASDAQ: RNA) is capturing the attention of investors with its groundbreaking approach to RNA therapeutics aimed at transforming the care for patients suffering from cardiomyopathies. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds